Archean Sciences files Form D for SAFE offering of indefinite size
The Champaign, Illinois biotechnology company reported $385,000 raised from eight investors under a Regulation D exemption.
Archean Sciences, Inc., a Delaware corporation based in Champaign, Illinois, filed a Form D notice with the Securities and Exchange Commission dated August 13, 2026, disclosing an exempt securities offering. The company was incorporated in 2026.1
The filing lists the date of first sale as May 27, 2026.1 The security type offered is described as a Simple Agreement for Future Equity, or SAFE.1 The offering claims exemption under Rule 506(b).1
According to the filing, the total offering amount is listed as indefinite, while the total amount sold is $385,000, with the total remaining to be sold also listed as indefinite.1 The filing states that eight investors have already invested in the offering.1 The minimum investment accepted from any outside investor is set at $5,000.1
The filing reports $0 in sales commissions and $0 in finders' fees.1 For use of proceeds directed to executive officers, directors, or promoters, the filing estimates $250,000.1
The company classifies its industry as biotechnology within the health care sector.1 Archean Sciences reported no revenues in the issuer size section of the filing.1
The filing names Austin Russell Ellis-Mohr as an executive officer and director, and Mattia Gazzola as a director, both listed with the same Champaign, Illinois address as the company.1 The Form D was signed by Austin Ellis-Mohr, identified as CEO, on August 13, 2026.1
The filing indicates the issuer does not intend for this offering to last more than one year.1 The offering is not being made in connection with a business combination transaction such as a merger or acquisition.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.